Division of Endocrinology & Metabolism

Gregory Steinberg


Professor, Division of Endocrinology, Department of Medicine

Canada Research Chair in Metabolism, Obesity and Type 2 Diabetes



Education and Professional Standing

Dr. Steinberg obtained his PhD in 2002 from the University of Guelph.   His research thesis was conducted in the laboratory of Professor David Dyck where he studied the regulation of metabolism in muscle by the hormone leptin.  From 2002-2006, Dr. Steinberg conducted Postdoctoral Research in the laboratory of  Professor Bruce Kemp at St. Vincent’s Institute of Medical Research in Melbourne, Australia.  During this time he gained insight into protein biochemistry and molecular biology with an emphasis on the metabolic stress sensing protein kinase AMPK.  In 2006, Dr. Steinberg became Head of the Metabolism Unit at St. Vincent’s Institute of Medical Research and a Senior Fellow of the National Health and Medical Research Council of Australia.   In 2009, Dr. Steinberg returned to Canada and joined the Department of Medicine, Endocrinology and Metabolism Division as an Associate Professor and Canada Research Chair.  His laboratory is currently funded by grants from CFI, CIHR, CDA and NSERC. 

Selected Publications

  • Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW, Zibrova D, Green KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR, Hardie GD. The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase. Science, 18:336 (6083):918-22, 2012. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399766/
  • Jorgensen SB, O’Neill HM, Sylow L, Honeyman J, Hewitt KA, Rengasamy P, Fullerton MD, Öberg L, Balendran A, Galic S, van der Poel C, Trounce IA, Lynch GS, Schertzer JD, Steinberg GR. Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity. Diabetes epub September 6, 2012 http://diabetes.diabetesjournals.org/content/early/2012/08/30/db12-0443.long

  • Rengasamy P, Fullerton MD, Galic S, Honeyman J, Hewitt K, Jorgensen SB, Steinberg GR. SOCS3 deletion from adipose tissue protects female mice against obesity-induced insulin resistance. Diabetologia, 55(11):3083-93, 2012. http://www.springerlink.com/content/l111t342748666g4/

  • Galic S, Fullerton MD, Schertzer JD, Sikkema S, Marcinko K, Honeyman J, Walkley CR, Chen Z-P, van Denderen BJ, Kemp BE,Steinberg GR.  Hematopoietic AMPK β1 prevents inflammation and hepatic insulin resistance in obesity.  Journal of Clinical Investigation. 121(12):4903-15, 2011.

  • O’Neill H, Maarbjerg S, Crane J, Jeppesen J, Jørgensen SB, Shyroka O, Schertzer J.D., vanDenderen BJ, Kiens, B., Tarnopolsky MA., Kemp BE, Richter EA, Steinberg GR. AMPK β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise.  Proceedings of the National Academy of Sciences.  108(38):16092-7, 2011.

  • Galic S, Oakhill J, Steinberg GR. The adipocyte as an endocrine organ. Molecular and Cellular Endocrinology 316(2):129-39, 2010. http://www.sciencedirect.com/science/article/pii/S0303720709004389

  • Steinberg GR and Kemp BE.  AMPK in Health and Disease.  Physiological Reviews. 89(3):1025-78, 2009.  http://physrev.physiology.org/content/89/3/1025.long